Non-Germinal Center B-cell Diffuse Large B-cel... - CLL Support

CLL Support

23,253 members39,949 posts

Non-Germinal Center B-cell Diffuse Large B-cell Lymphoma (DLBCL) may benefit most from Immunochemotherapy.

AussieNeil profile image
AussieNeilPartnerAdministrator
4 Replies

"Progression-free and overall survival were significantly longer in patients with non-GCB DLBCL who were treated with R-ACVBP compared with R-CHOP. No differences in survival between regimens were found for patients with GCB DLBCL."

More from the Cancer Network:

cancernetwork.com/news/non-...

Good to see there is work going on in (from Paris, France in this case) into what works best for the different types of DLBCL

Neil

Photo: Flowering sundew

Written by
AussieNeil profile image
AussieNeil
Partner
To view profiles and participate in discussions please or .
4 Replies
Cllcanada profile image
CllcanadaTop Poster CURE Hero

Actually, Non-Germinal Center B -Cell like DLBCL is not a Richter's transformation, per say, it is Activated B-cell like ABC-DLBCL or perhaps not otherwise specified or NOS-DLBCL, subtype.

RT-DLBCL is different genetically... and has two further subtypes... CLL clonal related and denovo.

en.m.wikipedia.org/wiki/Ger...

Anyway... ABC type is the hardest to treat, so this cocktail is good news... Also Imbruvica (ibrutinib) has shown to be active in this type.

A Phase II study in DLBCL found a clinically meaningful response to ibrutinib monotherapy (overall response rate [ORR] 40%, CR 8%) in the activated B-cell-like (ABC) molecular subtype, but not in the germinal B-cell-like (GBC) subtype (ORR 5%, CR 0%). Median PFS in the ABC responders was 5.5 months.

lymphomahub.com/agents/agen...

Here is the full paper

jco.ascopubs.org/content/ea...

~chris

AussieNeil profile image
AussieNeilPartnerAdministrator in reply toCllcanada

Thanks for the correction Chris. Are you able to reassure our community that there's virtually no risk of developing Non-Germinal Center B -Cell like DLBCL if you have CLL?

I've changed the title.

Neil

Cllcanada profile image
CllcanadaTop Poster CURE Hero in reply toAussieNeil

DLBCL is highly aggressive... any type... I know...

De novo could be any subtype of DLBCL ...it is MUCH more secondary cancer than a true Richter's... which is clearly CLL clone related in 80% of cases... but it might be related to the brake failure on the CLL immune system car post treatment...

This will be likely reclassified based on new genetic data... CLL and NOS

perhaps?

It is just how fine you want to slice the salami :-)

Richter's is VERY POORLY understood.. no reassurances... but RCHOP can and has been curative...

My prognosis... 6 months to a year... now I'm 24 months...

Don't believe the numbers, believe in yourselves... every day is a gift

Psmithuk profile image
Psmithuk in reply toCllcanada

keep going - five years next! All the best

Chris(UK)

Not what you're looking for?

You may also like...

Dr Sharman explains how treatment options for the two main subtypes of the aggressive Diffuse Large B Cell Lymphoma are changing

Diffuse Large B Cell Lymphomas are aggressive lymphomas that those of us with CLL face a chance of...
AussieNeil profile image
Partner

Ibrutinib vs FCR: does order of therapy matter?

Time for a really specific question that is at the nub of the decision faced by doctors and...
AdrianUK profile image

Richters Transformation

I recently informed here that after nine therapy free years since 2014 (FCR) my CLL bounced back in...
seoul1949 profile image

Treatment-naive or relapsed CLL patients will soon have zanubrutinib/Brukinsa as a treatment option in the EU

The EC approval is based on positive results from two Phase 3 clinical trials: SEQUOIA...
AussieNeil profile image
Partner

Acalabrutinib exhibits comparable efficacy, superior safety to ibrutinib for CLL (finally!)

Positive high-level results from the ELEVATE-RR Phase III trial showed AstraZeneca’s Calquence...
avzuclav profile image